The New Zealand market regulator has revealed lifting the suspension on the derivatives issuer licence of AxiCorp Financial Services Pty Limited. The suspension lift is effective since 2 December 2021.
FMA suspended AxiCorp’s derivatives issuer licence in June 2019. As a reason for the suspension, the New Zealand watchdog quoted material breaches of the Financial Markets Conduct Act 2013.
The regulator noted that the company has taken steps to address and remedy these breaches.
AxiCorp has since demonstrated to the FMA that it has taken adequate steps to address the material breaches and that it has adequate systems, processes and resources in place to ensure compliance with the FMC Act and to effectively perform services under the licence.
Earlier in March 2021, ASIC placed additional licence conditions on AxiCorp to ensure AxiCorp has adequate compliance arrangements in place for its OTC derivatives business.
Independent writer and journalist, working in the global online trading sector, Steffy is the Editor of LeapRate. She has previous experience as a copywriter and has been with the company since January 2020. Steffy has a British and American Studies degree from St. Kliment Ochridski University in Sofia.